Clinical Trial Update: Satisfaction and Compliance of Risedronate in PMO [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating satisfaction and adherence to risedronate in postmenopausal osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• risedronate (risedronate)

Snippet

Sponsor: Sanofi | Conditions: Osteoporosis, Postmenopausal | Phase 4 | Status: COMPLETED